December 5, 2018 — Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE marked. This injector is designed for injecting contrast agents used in computed tomography (CT) scan medical examinations.
This new solution includes the OptiVantage syringe-based injector, a complete range of associated syringes and disposables (manyFill day set and secufill patient line), services and support systems (OptiProtect).
OptiVantage multi-use will initially be marketed in Europe, the Middle East and Africa (EMEA) from January 2019, then progressively in other regions of the world (Asia and Latin America).
Existing OptiVantage customers may benefit from an upgrade to easily implement the new multi-use feature.
Launched in 2005, the OptiVantage injector is a Class IIb medical device intended for use by medical imaging and diagnostic health professionals, for injecting radiopaque contrast media and saline into a patient's vascular system during CT examinations. The new version is adapted to multi-use markets and is available in pedestal and ceiling-mount versions.
For more information: www.guerbet.com
March 25, 2026 
